And you keep inferring that they wouldn't carry out steps in the approval process without having completed a previous step ie. already made a decision to grant approval.
Not what I said at all in not one but two separate posts .... just to be clear:
"the FDA must have been at least somewhat satisfied with the data in the BLA resubmission"
"they weren't at least somewhat happy with the data provided by Mesoblast in the BLA resubmission"
..... neither of these statements make claims that a decision has been made to grant approval causing the inspection to be undertaken .... more lies from you - do better !
And you keep inferring that they wouldn't carry out steps in the...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.065(4.66%) |
Mkt cap ! $1.667B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.50 | $1.40 | $5.699M | 3.943M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 122380 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 11015 | 2 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |